Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2005
12/28/2005CN1712524A HIV-1 resistance strain and use thereof
12/27/2005US6979568 Vector for the expression of two foreign genes
12/27/2005US6979538 Directed evolution of novel binding proteins
12/27/2005US6979535 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
12/27/2005US6979448 Particles created by insertion of Mucin peptide epitopes into a plant virus (cowpea mosaic virus) with beta-barrel structure in its coat protein; good mucosal immunity with intranasal vaccine
12/22/2005WO2005121376A2 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant
12/22/2005WO2005121325A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005WO2005120579A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
12/22/2005WO2005082020A3 Flavivirus vaccines
12/22/2005WO2005052116A3 Preservative-containing virus formulations
12/22/2005WO2004027037A3 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
12/22/2005US20050282282 Methods of use of viral vectors to deliver antigen to dendritic cells
12/22/2005US20050282280 Oncolytic adenoviral vectors encoding GM-CSF
12/22/2005US20050282279 Expression vector encoding coronavirus-like particle
12/22/2005US20050282263 Flexible vaccine assembly and vaccine delivery platform
12/22/2005US20050282251 Heparanase II, a novel human heparanase paralog
12/22/2005US20050282155 Viral libraries from uncultivated viruses and polypeptides produced therefrom
12/22/2005US20050282154 Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005CA2570050A1 Heart and skeletal muscle inflammation (hsmi) virus
12/21/2005EP1606411A1 Mutant vesicular stomatitis viruses and use thereof
12/21/2005EP1606397A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
12/21/2005EP1606391A2 Virulent systemic feline calicivirus
12/21/2005EP1404852B1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
12/21/2005EP1250161B1 Polymer blends as biodegradable matrices for preparing biocomposites
12/21/2005EP1238057B1 Method for producing adherent animal cells
12/21/2005EP1165815B1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
12/21/2005EP0920524B1 A short-shafted adenoviral fiber and its use
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711352A Highly permissive cell lines for hepatitis C virus replication
12/21/2005CN1232636C Method for detecting human tumor antigen P185 Her-2 and its application in diagnosing tumor
12/20/2005US6977079 Avian pneumovirus vaccine
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/15/2005WO2005118825A2 Chimeric adenoviruses for use in cancer treatment
12/15/2005WO2005118792A1 Compositions and methods to prevent aav vector aggregation
12/15/2005WO2005117983A2 Carrier conjugates of tnf-peptides
12/15/2005WO2005108560A3 Synthesis and purification of west nile virus virus-like particles
12/15/2005WO2005039501A3 Immunogenic composition and method of developing a vaccine based on fusion protein
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2003029409A3 Methods for generating, selecting, and identifying compounds which bind a target molecule
12/15/2005US20050277194 Complementing cell lines
12/15/2005US20050277193 Vectors and methods for gene transfer
12/15/2005US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond
12/15/2005US20050276816 Infectious DNA as a vaccine against west nile and other flavivirues
12/15/2005CA2836987A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2716426A1 Inactivation of a pathogen in a sample by a treatment with formalin and uv light
12/15/2005CA2569244A1 Compositions and methods to prevent aav vector aggregation
12/15/2005CA2567094A1 Chimeric adenoviruses for use in cancer treatment
12/14/2005EP1605064A1 HIV Variant showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant virus
12/14/2005EP1605053A1 Use of adenoviruses mutated in the VA genes for cancer treatment
12/14/2005EP1605047A1 Chimeric and/or growth-restricted flaviviruses
12/14/2005EP1604685A2 An attenuated japanese encephalitis virus
12/14/2005EP1604020A2 Method to confer cell culture replication activity to different hepatitis c virus isolates
12/14/2005EP1603940A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
12/14/2005EP1603939A2 Recombinant human metapneumovirus and its use
12/14/2005CN1231598C Process for recombining aviadenovirus
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231587C Beet black withered virus as expression carrier of foreigh gene
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231263C Foot-and-mouth disease virus antigen preservation technology
12/13/2005US6974866 Retrovirus from the HIV type O and its use (MVP-2901/94)
12/13/2005US6974695 Complementing cell lines
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974575 Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
12/13/2005CA2214837C Method of purification of recombinant viral vectors containing a therapeutic gene
12/08/2005WO2005116260A2 Influenza hemagglutinin and neuraminidase variants
12/08/2005WO2005116258A2 Influenza hemagglutinin and neuraminidase varians
12/08/2005WO2005115448A2 Multi plasmid system for the production of influenza virus
12/08/2005WO2005026378B1 Methods for gene function analysis
12/08/2005US20050273869 Plasmids and phages for homologous recombination and methods of use
12/08/2005US20050272031 Viral variants and uses therefor
12/08/2005US20050272029 Hepatitis c viral-like particle purification
12/08/2005US20050271688 Modified vaccinia ankara virus variant
12/08/2005US20050271687 Retrovirus-like particles made non-infectious by a plurality of mutations
12/08/2005US20050271686 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
12/08/2005US20050271685 Cellular permissivity factor for viruses and uses thereof
12/08/2005US20050271622 Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
12/08/2005US20050271621 Ablated slam-dependent entry
12/08/2005US20050271620 Herpes simplex virus complex
12/08/2005CA2822895A1 Influenza hemagglutinin and neuraminidase variants
12/08/2005CA2568020A1 Influenza hemagglutinin and neuraminidase variants
12/08/2005CA2568015A1 Influenza hemagglutinin and neuraminidase variants
12/07/2005EP1601333A2 Novel insertion sites in pox vectors
12/07/2005EP1601327A2 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0922105B1 Infectious papillomavirus pseudoviral particles
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1705740A Adenovirus expressing genes in reverse order and use thereof
12/07/2005CN1230531C Method for separating cell particle from sample
12/07/2005CN1230526C Method for removing organic solvent and/or detergent used as virus inactivator
12/07/2005CN1230206C Polymer blends as biodegradable matrices for preparing biocomposites
12/06/2005CA2164324C Generation concentration and efficient transfer of vsv-g pseudotyped retroviral vectors
12/01/2005WO2005113782A1 Tc-83-derived alphavirus vectors, particles and methods
12/01/2005WO2005113758A1 Process for the production of an influenza vaccine
12/01/2005WO2005113757A1 Apparatus for the disruption of animal cells
12/01/2005WO2005113756A1 Method
12/01/2005WO2005113059A2 Disruption of the processing of the viral capsid-spacer peptide 1 protein
12/01/2005WO2005112994A1 Nodavirus-vlp immunization composition
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 267